Pessoa M G, Bzowej N, Berenguer M, Phung Y, Kim M, Ferrell L, Hassoba H, Wright T L
Department of Veterans Affairs Medical Center, University of California, San Francisco 94121, USA.
Hepatology. 1999 Dec;30(6):1513-20. doi: 10.1002/hep.510300610.
Evolution of hepatitis C quasispecies may be one mechanism by which fibrosing cholestatic hepatitis develops after liver transplantation. In this study, we compared changes in quasispecies complexity and/or divergence in (1) hepatitis C-infected immunosuppressed transplant recipients and in immunocompetent controls; (2) transplant recipients with mild recurrence, and in those with the most severe form of posttransplantation recurrence. Quasispecies were measured in 12 hepatitis C-infected patients pretransplantation and posttransplantation (6 with mild and 6 with severe recurrence), and in 5 immunocompetent patients with similar follow-up, and characterized by heteroduplex mobility and sequence analysis of the hypervariable region. Although the number of variants (complexity) did not change with time in either group, there was a qualitative change in the variants with time (divergence) in immunocompromised, but not in immunocompetent patients. These changes were most marked with severe recurrence, and preceded the development of severe disease. Phylogenetic analysis confirmed that most posttransplantation variants were unrelated to those detected pretransplantation. These observations suggest that in the absence of immune suppression, there is minor evolution of quasispecies. With immune suppression, divergence of quasispecies is enhanced, resulting in selection/emergence of many new variants, particularly in those with fibrosing cholestatic hepatitis. Thus, quasispecies may influence disease progression in immune suppressed populations.
丙型肝炎准种的演变可能是肝移植后发生纤维化胆汁淤积性肝炎的一种机制。在本研究中,我们比较了以下两组人群中准种复杂性和/或差异的变化:(1)丙型肝炎感染的免疫抑制移植受者和免疫功能正常的对照者;(2)轻度复发的移植受者和移植后复发最严重形式的受者。在12例丙型肝炎感染患者移植前和移植后(6例轻度复发和6例重度复发)以及5例有类似随访的免疫功能正常患者中测量准种,并通过异源双链迁移率和高变区序列分析进行表征。尽管两组中变异体数量(复杂性)均未随时间变化,但免疫受损患者的变异体随时间有质的变化(差异),而免疫功能正常患者则没有。这些变化在重度复发时最为明显,并先于严重疾病的发生。系统发育分析证实,大多数移植后变异体与移植前检测到的变异体无关。这些观察结果表明,在没有免疫抑制的情况下,准种的演变较小。有免疫抑制时,准种的差异增强,导致许多新变异体的选择/出现,尤其是在患有纤维化胆汁淤积性肝炎的患者中。因此,准种可能影响免疫抑制人群中的疾病进展。